LYZ and sarcoidosis: While increased CTO is not specific for sarcoidosis, the enzyme has proven to be a very sensitive biomarker of active sarcoidosis and has more sensitivity and specificity than other commonly used sarcoid biomarkers such as ACE and lysozyme [1,40].